Healthcare AI News 5/21/25

News

AI clinical documentation company Abridge is reportedly looking to raise new funding that would put its valuation at $5 billion, double its value earlier this year when it announced $250 million in Series D funding. The company has raised $475.5 million since getting its start in 2018. I interviewed Abridge founder and CEO Shiv Rao, MD back in 2023.

Business

New Mountain Capital combines portfolio RCM companies SmarterDx, Thoughtful.ai, and Access Healthcare to create AI-powered healthcare revenue management company Smarter Technologies.

PsychNow develops Chapter, an AI consultation copilot that helps behavioral health providers capture the contextual details of a patient’s story before the first appointment.

OmniMD announces GA of AI Clinicians, an AI assistant that incorporates clinical data, predictive analytics, and real-time decision support.

Onvida Health (AZ) will pilot AI clinical documentation software from Ambience Healthcare this summer.

Research

UnitedHealth Group’s Optum division is working with researchers at the Duke-Margolis Institute for Health Policy to automate Medicare risk coding using AI.

A Phyx Primary Care Innovation Lab survey of 120 physicians determines that their use of Navina’s AI Copilot helped to reduce clinical review time for complex visits by 40%.

Other

Stony Brook Medicine’s cardiology and radiology departments develop HeartFlow Plaque Analysis, an AI imaging tool that assesses a patient’s coronary artery disease and informs treatment plans.

Duke Health (NC) will work with Microsoft services company Avanade to develop an AI governance process for the responsible implementation of clinical AI in healthcare settings.

The DOD’s US Military Entrance Processing Command develops and begins using an AI summary tool to streamline the review of applicant medical documents during the medical pre-screening process.

Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Follow on X, Bluesky, and LinkedIn.
Sponsorship information.
Contact us.